封面
市场调查报告书
商品编码
1866522

全球消化酵素市场:预测(2025-2030 年)

Global Digestive Enzymes Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球消化酵素市场规模预计将从 2025 年的 864,094,000 美元成长到 2030 年的 1,245,720,000 美元,复合年增长率为 7.59%。

由于胃肠道疾病和腹部疾病的增加,以及人们对预防医学日益增长的兴趣,全球消化酵素市场预计将迎来显着增长。消化酵素是能够将大分子分解成可吸收成分的复杂蛋白质,其最佳功能需要特定的pH值和温度条件。这些酵素作为非处方补充剂出售,能够有效缓解常见的消化器官系统问题,例如胀气、腹胀、消化不良、胃灼热和一般不适。饮食习惯的改变和人口老化是推动市场成长的主要因素,但来自益生菌和益生元等替代产品的竞争也对市场成长构成挑战。

市场驱动因素

胃肠道和腹部疾病发病率的上升是推动消化酵素补充剂市场成长的主要因素。为了缓解这些症状并维持健康的消化功能,人们对消化酵素补充剂的需求日益增长。老年人口的增长,由于酵素分泌老龄化增长而减少,更容易出现消化器官系统问题,这进一步促进了市场扩张。此外,消费者对预防性健康管理意识的提高,也推动了消化酵素补充剂作为积极健康策略的一部分的需求。不健康的饮食习惯,例如食用加工食品和不规则的饮食,会加剧消化器官系统问题,从而增加了对酵素製剂的需求。

市场限制

益生菌和益生元等替代消化健康产品的存在对市场成长构成了挑战,这些产品透过不同的机制促进肠道健康,并争夺消费者的偏好,这可能会限制消化酵素补充剂在某些细分市场的普及。

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 全球消化酵素市场(按类型划分)

  • 介绍
  • 蛋白酶
  • 脂肪酶
  • 乳糖酶
  • 淀粉酶
  • 其他的

6. 全球消化酵素市场(依来源划分)

  • 介绍
  • 动物源性
  • 植物来源
  • 微生物来源

7. 全球消化酵素市场(按应用领域划分)

  • 介绍
  • 运动营养
  • 婴儿营养
  • 医学营养
  • 其他的

8. 全球消化酵素市场(按地区划分)

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 併购、协议和合作
  • 竞争对手仪錶板

第十章:公司简介

  • Enzymedica
  • Deerland Enzymes, Inc.(Archer Daniels Midland)
  • AST Enzymes
  • Onnit Labs, Inc
  • Metagenics
  • National Enzyme Company Inc.
  • Abbott Laboratories
  • Amway Corporation
  • Country Life, LLC
  • Biotics Research Corporation
  • Klaire Labs
  • Integrative Therapeutics LLC

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611927

The Digestive Enzymes Market is anticipated to climb from USD 864.094 million in 2025 to USD 1,245.720 million by 2030, with a 7.59% CAGR.

The global digestive enzymes market is poised for significant growth, driven by the increasing prevalence of gastrointestinal and abdominal disorders and a growing focus on preventive health management. Digestive enzymes, complex proteins that break down macromolecules into absorbable constituents, require specific pH and temperature conditions to function optimally. Available as commercial supplements, these enzymes effectively alleviate common digestive issues such as gas, bloating, indigestion, heartburn, and general discomfort. The market is propelled by shifts in dietary habits and an aging population, though competition from alternative products like probiotics and prebiotics presents challenges to growth.

Market Drivers

The rising incidence of gastrointestinal and abdominal disorders is a primary driver, as these conditions increase demand for digestive enzyme supplements to manage symptoms and support healthy digestion. The growing geriatric population, which is more prone to digestive issues due to age-related declines in enzyme production, further fuels market expansion. Additionally, increasing consumer awareness of preventive health management is driving demand for digestive enzyme supplements as part of proactive wellness strategies. The shift away from healthy eating habits, characterized by processed foods and irregular diets, exacerbates digestive issues, boosting the need for enzyme-based solutions.

Market Restraints

The availability of alternative digestive health products, such as probiotics and prebiotics, poses a challenge to market growth. These alternatives, which promote gut health through different mechanisms, compete for consumer preference and may limit the adoption of digestive enzyme supplements in certain segments.

Market Segmentation

While specific segmentation details are not provided, the digestive enzymes market likely includes categories such as product type (e.g., single-enzyme or multi-enzyme supplements), application (e.g., digestive disorder management, general wellness), and end-user (e.g., adults, geriatrics). Geographically, the market spans regions with high healthcare awareness, such as North America and Europe, with emerging markets in Asia-Pacific showing growth potential due to rising health consciousness and disposable incomes. The supplements are distributed through retail pharmacies, e-commerce platforms, and health food stores, catering to diverse consumer needs.

Key Players

Major companies in the digestive enzymes market include Enzymedica, Deerland Enzymes, Inc., AST Enzymes, Onnit Labs, Inc., Metagenics, National Enzyme Company Inc., Garden of Life Inc., Amway Corporation, and Country Life, LLC. These players are focusing on product innovation, such as developing targeted enzyme formulations, and expanding distribution channels to strengthen their market positions. Strategic partnerships and marketing efforts emphasizing preventive health are also key to their competitive strategies.

Market Insights

The market analysis highlights the growing demand for digestive enzyme supplements, driven by health trends and demographic shifts. The report likely incorporates data on sales trends, consumer preferences, and regulatory frameworks, providing a comprehensive view of market dynamics. The emphasis on preventive health and the rising burden of digestive disorders underscore the market's growth potential.

In conclusion, the digestive enzymes market is set for robust growth, driven by the increasing prevalence of gastrointestinal disorders, an aging population, and heightened health awareness. North America and Europe are key markets, with Asia-Pacific emerging due to rising consumer spending. However, competition from probiotics and prebiotics may temper growth. Leading companies are leveraging innovation and strategic marketing to capitalize on the demand for digestive health solutions, ensuring sustained market expansion.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Type

  • Protease
  • Lipase
  • Lactase
  • Amylase
  • Others

By Source

  • Animal
  • Plant
  • Microbial

By Application

  • Sports Nutrition
  • Infant Nutrition
  • Medical Nutrition
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL DIGESTIVE ENZYMES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Protease
  • 5.3. Lipase
  • 5.4. Lactase
  • 5.5. Amylase
  • 5.6. Others

6. GLOBAL DIGESTIVE ENZYMES MARKET BY SOURCE

  • 6.1. Introduction
  • 6.2. Animal
  • 6.3. Plant
  • 6.4. Microbial

7. GLOBAL DIGESTIVE ENZYMES MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Sports Nutrition
  • 7.3. Infant Nutrition
  • 7.4. Medical Nutrition
  • 7.5. Others

8. GLOBAL DIGESTIVE ENZYMES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Enzymedica
  • 10.2. Deerland Enzymes, Inc. (Archer Daniels Midland)
  • 10.3. AST Enzymes
  • 10.4. Onnit Labs, Inc
  • 10.5. Metagenics
  • 10.6. National Enzyme Company Inc.
  • 10.7. Abbott Laboratories
  • 10.8. Amway Corporation
  • 10.9. Country Life, LLC
  • 10.10. Biotics Research Corporation
  • 10.11. Klaire Labs
  • 10.12. Integrative Therapeutics LLC

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations